DCB Club 2025 — Day 1

DCB Club 2025 — Day 1

16 of 19 videos summarized

DCB Club 2025 — Day 1 FRIDAY 7th NOVEMBER: 12:45 – 13:00: Welcome and Opening Remarks – Franz Kleber & Ulf Landmesser Session 1: Introduction to Drug-Coated Balloons 12 min: Histopathological Basis of CAD – Michael Joner 12 min: Current and Emerging Indications in ISR and de novo Lesions – Fernando Alfonso 12 min: Key Recent and Future Trials – Raban Jeger Session 2: Histopathology and Imaging in CAD 3 min: A word about the last 20 years – Patrick Serruys 10 min: Imaging with Angiography – Franz Kleber 12 min: Intravascular Imaging: IVUS & OCT – Eun-Seok Shin 12 min: Other Imaging Modalities (e.g., NIRS, CT) – Bimmer Claessen 12 min: Characterizing vulnerable plaques – Elaaha Anwari 12 min: Drug delivery: Lessons from the Visible Heart Lab – Azeem Latib 8 min: Impact of thrombus on neointima, restenosis and flow – Patrick Serruys Session 3 - BBRAUN - BBraun DCB unplugged – Stories from the past and glimpse into the future 2 min: Opening Remarks – Bruno Scheller 6 min: DCB’s Journey: From local innovation to global therapy. A deeper look into the development and worldwide spread of DCB technology – Bruno Scheller 6 min: Believing Early: The Malaysian Experience. Why Malaysia embraced DCB early on, how it gained clinical acceptance, and what made the technology so compelling – Mohd Ali Rosli 6 min: Where Stents fail: The expanding role of DCB. Future applications of DCB in complex cases and drug choice-including real-world examples – Tuomas Rissanen Session 4: Technical Strategies 12 min: Lesion Preparation – Victor Jimenez 12 min: Scoring and High-Pressure Balloons – Adnan Kastrati 12 min: Impact of lesion characteristics on DCB success – Takashi Ashikaga 12 min: IVUS evaluation of dissections and healing – Yoshihisa Shimada Session 5 - CORDIS - DCB after SELUTION DeNovo RCT: Translating Evidence to Practice 7 min: Welcome & Opening Remarks – Fernando Alfonso 10 min: Redefining PCI treatment after SELUTION DeNovo – David Hildick-Smith • DeNovo Case presentation & PCI Treatment Strategy • Discussion - what does SELUTION DeNovo tells us? • Key insights from the SELUTION DeNovo RCT 5 min: Key Takeaways & future perspectives – Fernando Alfonso

Session 4: Technical Strategies - IVUS evaluation of dissections and healing – Yoshihisa Shimada13:39

Session 4: Technical Strategies - IVUS evaluation of dissections and healing – Yoshihisa Shimada

Nov 15, 2025

Session 1: Introduction to Drug-Coated Balloons - Key Recent and Future Trials – Raban Jeger1:08

Session 1: Introduction to Drug-Coated Balloons - Key Recent and Future Trials – Raban Jeger

Nov 15, 2025

CORDIS - Redefining PCI treatment after SELUTION DeNovo – David Hildick-Smith6:43

CORDIS - Redefining PCI treatment after SELUTION DeNovo – David Hildick-Smith

Nov 15, 2025

CORDIS - DCB after SELUTION DeNovo RCT: Welcome & Opening Remarks – Fernando Alfonso10:02

CORDIS - DCB after SELUTION DeNovo RCT: Welcome & Opening Remarks – Fernando Alfonso

Nov 12, 2025

Session 4: Technical Strategies - Impact of lesion characteristics on DCB success – Takashi Ashikaga12:43

Session 4: Technical Strategies - Impact of lesion characteristics on DCB success – Takashi Ashikaga

Nov 12, 2025

Session 4: Technical Strategies - Scoring and High-Pressure Balloons – Adnan Kastrati11:03

Session 4: Technical Strategies - Scoring and High-Pressure Balloons – Adnan Kastrati

Nov 12, 2025

Session 4: Technical Strategies - Lesion Preparation – Victor Jimenez Diaz14:00

Session 4: Technical Strategies - Lesion Preparation – Victor Jimenez Diaz

Nov 12, 2025

Session 3: BBRAUN - Future applications of DCB in complex cases and drug choice – Tuomas Rissanen11:19

Session 3: BBRAUN - Future applications of DCB in complex cases and drug choice – Tuomas Rissanen

Nov 12, 2025

Session 3 - BBRAUN - Why Malaysia embraced DCB early on... – Mohd Ali Rosli8:38

Session 3 - BBRAUN - Why Malaysia embraced DCB early on... – Mohd Ali Rosli

Nov 12, 2025

Session 3:  BBRAUN - DCB’s Journey: From local innovation to global therapy – Bruno Scheller11:52

Session 3: BBRAUN - DCB’s Journey: From local innovation to global therapy – Bruno Scheller

Nov 12, 2025

Session 2: Impact of thrombus on neointima, restenosis and flow – Patrick Serruys5:38

Session 2: Impact of thrombus on neointima, restenosis and flow – Patrick Serruys

Nov 12, 2025

Session 2: Histopathology and Imaging in CAD 5. Characterizing vulnerable plaques – Elaaha Anwari10:11

Session 2: Histopathology and Imaging in CAD 5. Characterizing vulnerable plaques – Elaaha Anwari

Nov 12, 2025

Session 2: Histopathology and Imaging in CAD - Intravascular Imaging: IVUS & OCT – Eun-Seok Shin14:18

Session 2: Histopathology and Imaging in CAD - Intravascular Imaging: IVUS & OCT – Eun-Seok Shin

Nov 12, 2025

Session 2: Histopathology and Imaging in CAD - Imaging with Angiography – Franz Kleber10:48

Session 2: Histopathology and Imaging in CAD - Imaging with Angiography – Franz Kleber

Nov 12, 2025

Session 2: Histopathology and Imaging in CAD - A word about the last 20 years – Patrick Serruys4:23

Session 2: Histopathology and Imaging in CAD - A word about the last 20 years – Patrick Serruys

Nov 12, 2025

Session 1: Current and Emerging Indications in ISR and de novo Lesions – Fernando Alfonso11:12

Session 1: Current and Emerging Indications in ISR and de novo Lesions – Fernando Alfonso

Nov 12, 2025